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Purpose: To test the hypothesis that lower extremity transcutaneous oxygen (TcPO2) 
measurements can accurately predict severity of foot ischemia nd can be used to select 
appropriate reatment (conservative rsus operative) for patients with diabetes and tissue 
necrosis or ischemic rest pain. 
Methods: Fifty-five patients with 66 limbs were prospectively treated from June 1993 to 
July 1994. Noninvasive hemodynamic arterial assessment and TcPO2 mapping of the 
involved limb were obtained before treatment was selected. If the transmetatarsal TcPO 2 
level was 30 mm Hg or greater, the patient's foot problem was managed conservatively 
'with local wound care, debridement, or a minor foot amputation. If the transmetatarsal 
TcPO e level was less than 30 mm Hg, arteriography was performed with the anticipated 
need for vascular econstruction. The endpoints for determining treatment success or 
failure were complete wound healing or relief of ischemic rest pain. 
Results: Thirty-one of 36 (86%) limbs with an initial transmetatarsal TcPO 2 level of 30 mm 
Hg or greater were treated successfully with conservative care, including 73% (11 of 15 
feet) of limbs without a palpable pedal pulse. After either bypass or angioplasty, 20 of 24 
(83%) limbs achieved a transmetatarsal TcPO 2 level greater than 30 mm Hg and had 
complete resolution of their presenting foot problem. An initial or postintervention 
transmetatarsal TcPO 2 level of 30 mm Hg or greater was more accurate (90%,p = 0.001) 
than a palpable pedal pulse (65%, p = 0.009), in predicting ultimate wound healing or 
resolution of rest pain. 
Conclusions: TcPO 2 mapping is a useful noninvasive modality that can prospectively 
determine severity of foot ischemia, aid in selecting appropriate reatment for patients with 
diabetes and foot salvage problems, and decrease the total cost of such care. (J VASC SURG 
1995;22:485-92.) 
Successful treatment of the patient with diabetes 
and limb-threatening schemia requires an accurate 
assessment of limb perfusion. A patient's ymptoms 
may be misleading. Physical examination of  periph- 
eral pulses or the ankle/brachial index (ABI) may be 
inaccurate. Often, the cause of the presenting foot 
problem is likely to be multifactorial. A noninvasive, 
inexpensive, and reproducible diagnostic test that 
could reliably predict severity of foot ischemia would 
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be useful. Commonly used noninvasive lower ex- 
tremity hemodynamic studies lack discriminative 
accuracy) -4Arteriography is invasive, expensive, and 
carries a small but well-defined set of associated 
complications, s-6However, transcutaneous measure- 
ment of the partial pressure of oxygen (TcPO2) has 
application in peripheral vascular surgery. It has been 
used for monitoring results of arterial revasculariza- 
tion, assessing limb ischemia, and determining an 
optimal amputation level) -4,712 
This study tests the hypothesis that TcPO2 
measurements can be used to select appropriate 
treatment (conservative rsus operative) for patients 
with diabetes with severe chronic foot ischemia nd 
its complications. 
PATIENTS AND METHODS 
During the period June 1993 to July 1994, all 
parents with diabetes and ischemic rest pain or pedal 
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tissue necrosis were prospectively entered into the 
study. 13 A detailed medical history and physical 
examination was obtained by use of conventional nd 
time-tested techniques as follows: pedal pulses were 
documented by the attending surgeon as either 
palpable or nonpalpable; a bilateral lower extremity 
noninvasive arterial evaluation recorded Doppler 
waveforms, egmental limb pressures, and calculated 
ABIs. In addition, transcutaneous oxygen mapping 
of the involved limb was performed (Novametrix 
System 800 monitor; Novametrix Medical Systems, 
Wallingford, Conn.) before treatment was selected. 
TcPO 2 mapping was performed at ambient room 
temperature with the patient in the supine position. 
Oxygen inhalation, change in limb position, and 
chest wall normalized TcPO 2 values were not used in 
this study. ~1,14,1s The Novametrix 800 monitor has 
three modified Clark electrodes that simultaneously 
record skin oxygen tension. Measurements were 
recorded from the dorsum of the foot (transmetatar- 
sal), the medial side of the calf8 to 10 cm below the 
knee (BK), and the medial side of the thigh 8 to 10 
cm above the knee (AK). On the skin surface, the 
oxygen sensor was held in place by a double-sided 
adhesive ring, and the controlled heating element 
around the sensor was adjusted to 44 ° C. Heating the 
sensor created local skin hyperemia,  decrease inflow 
resistance, and compensatory arterialization of cap- 
illary blood. This effectively raises the Po 2 and 
decreases the Pco2, values toward arterial evels) 6'17 
Stable TcPO 2 readings were usually achieved in 20 to 
30 minutes. 
Based on clinical experience and amputation 
level determination data, an absolute transmetatarsal 
TcPO 2 measurement of 30 mm Hg was used as the 
critical value to select a treatment option. 79 If the 
level was 30 mm Hg or greater, the patient's foot 
was managed conservatively with local wound care, 
wound debridement, or a minor foot amputation. 
If the level was less than 30 mm Hg, arteriography 
of the involved limb was performed to plan arterial 
reconstruction to improve foot perfusion. 
There were 34 (62%) men and 21 (38%) 
women with diabetes with a mean age of 67 years 
(range 34 to 87) entered into this study. They were 
admitted with 66 threatened feet for evaluation. 
Treatment indications included nonlaealing ulcer 
(35 feet, 53%), gangrene (25 feet, 38%), and rest 
pain (6 feet, 9%). Thirty-three (60%) patients had 
insulin-dependent diabetes, and the others (22 pa- 
tients, 40%) had noninsulin-dependent diabetes. 
Risk factors for peripheral vascular disease, in ad- 
dition to diabetes mellitus, included coronary artery 
disease (34 patients, 62%), hypertension (39 pa- 
tients, 71%), hypercholesterolemia (31 patients, 
56%), and history of smoking (I5 patients, 27%). 
Additionally, I2 (22%) patients were undergoing 
dialysis, and seven (13%) patients had a history of 
a previous stroke. In this medically compromised 
group, 31% (17 patients), had a previous history 
of lower extremity amputation (toe, six patients; 
transmetatarsal, three patients; below-knee (BK), 
five patients; above-knee (AK), three patients). 
All patients were examined at weekly or biweekly 
intervals. Follow-up TcPO 2 mapping, repeat pedal 
pulse examination, and recalculation of the ABI was 
performed in all patients who had a procedure de- 
signed to improve foot perfusion. Dressing changes 
were either performed by a family member or a home 
health care nurse specialist. The endpoints for deter- 
mining treatment success or failure were complete 
wound healing or relief of ischemic rest pain. All 
limbs, except four, reached these endpoints. 
Follow-up ranged from 2 to 15 months (mean 8 
months). No patient was lost to follow-up. 
Statistical analysis. Accuracy statistics were 
derived by use of 2 x 2 tables, and other conditional 
variables were evaluated by use of chi-squared or 
Fisher's exact est. The Student t statistic was used for 
testing the significance of differences in the means of 
independent and paired samples. A significant differ- 
ence for any statistical analysis was assumed when 
p < 0.05. Initial and follow-up ABIs unable to be 
calculated because of noncompressible v ssels were 
not used for statistical analysis. 
RESULTS 
In the conservative treatment group (38 feet, 
57.6%) with initial transmetatarsal TcPO 2 greater 
than 30 mm Hg, the mean ABI was 0.91 in the 
involved limb and the mean initial TcPO 2 levels were 
as follows: AK, 59 mm Hg; BK, 54 mm Hg; 
transmetatarsal, 50 mm Hg. A pedal pulse was 
palpated in 21 feet, whereas 17 feet did not have a 
palpable pedal pulse. Conservative treatment con- 
sisted of local wound care (16 feet, 42%), local 
wound debridement (18 feet, 47%), or a minor foot 
amputation (4 feet, 11%) (Table I). Thirty-six of 38 
feet were monitored to the selected endpoints. Two 
patients (two limbs with palpable pedal pulses) 
excluded from outcome analysis died 2 and 4 months 
after initiation of conservative care but before com- 
plete resolution of their presenting foot problem. 
Thirty-one of 36 (86%) limbs in this group were 
treated successfially, including 73% (11/15 feet) of 
limbs without a palpable pedal pulse. The mean time 
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to wound healing was 6.85 weeks. There were five 
treatment failures. One patient had a successful 
transmetatarsal amputation after conservative efforts 
failed to heal multiple nonhealing toe ulcers. The 
other four patients underwent arterial reconstruction 
(two femoropopliteal, one femorotibial, one pop- 
liteal-popliteal), with three successes and one failure, 
necessitating a BK amputation. 
In the operative treatment group (28 feet, 42.4%) 
with initial transmetatarsal TcPO 2 less than 30 mm 
Hg, the mean ABI in the involved limb was 0.57, and 
TcPO 2 mapping demonstrated the following mean 
values: AK, 55 mm Hg; BK, 41 mm Hg; transmeta- 
tarsal, 11 mm Hg. No patient in this group had a 
palpable pedal pulse, and all patients with rest pain 
had low transmetatarsal TcPO2 measurements. In-
terventions based on arteriography included arterial 
reconstruction (16 limbs, 57%), angioplasty (eight 
limbs, 29%), primary major amputation (two limbs, 
7%), and pedal vessel exploration (one limb, 3.5%). 
One other limb (3.5%) demonstrated only a proxi- 
mal occlusion of the lateral branch of the plantar 
artery without another significant arteriographic 
abnormality (Table I). Twenty-six of 28 feet were 
monitored to the selected endpoints. There were no 
deaths, but two patients without a distal target vessel 
suitable for bypass underwent primary major lower 
extremity amputation and were excluded from out- 
come analysis. 
After either bypass or angioplasty, 20 of 24 
(83.3%) limbs achieved a transmetatarsal TcPO 2 
level greater than 30 mm Hg. The TcPO 2 improve- 
ment was most marked at the transmetatarsal level 
where the mean value increased from 11 to 42 mm 
Hg (p = 0). At the BK and AK positions, the mean 
TcPO 2 level improved from 40 to 49 mm Hg 
(p = 0.11) and from 56 to 60 mm Hg (p = 0.43), 
respectively. Twenty-two f 26 (85%,p = 0.0003) 
limbs in this group had complete resolution of their 
presenting foot problem. This includes one limb with 
a persistent transmetatarsal TcPO 2 level less than 30 
mm Hg despite successful peroneal artery bypass, 
and one limb that had an unnecessary angiogram as 
the follow-up transmetatarsal TcPO 2 level after 
edema/cellulitis resolution was greater than 30 mm 
Hg. The mean time to wound healing was 9.52 
weeks. Treatment failures eventually ed to three BK 
amputations (one failed necessitating revision to the 
AK level) and 1 AK amputation. 
Overall, the pedal pulse examination was more 
accurate than the ABI in predicting TcPO 2 values 
above or below 30 mm Hg at the foot level (74%, 
p = 0.000006 vs 68%, p = 0.011). An abnormal 
Table I. Interventions based on initial 
transmetatarsal TcPO 2 level 
Transmetatarsal TcPO 2 > 30 mm Hg (38 feet, 57.6%) 
Wound debridement 18 feet (47%) 
Local wound care 16 feet (42%) 
Minor foot amputation 4 feet (11%) 
Transmetatarsal TcPO 2 < 30 mm Hg (28 feet, 42.4%) 











Primary major amputation 2 limbs (7%) 
BK 2 
Pedal vessel exploration I foot (3.5%) 
Essentially normal arteriogram 1 limb (3.5%) 
Fern, Femoral; Pop, popliteal; Tib, tibial; SFA, superficial femoral 
artery. 
arteriogram was predicted by both a low transmeta- 
tarsal TcPO 2 level and the absence of a palpable pedal 
pulse (27 of 28 threatened limbs, 96%), but not an 
ABI less than 0.60 (52%). The presence of a pedal 
pulse was 100% accurate for identifying limbs with a 
transmetatarsal TcPO 2 greater than 30 mm Hg (21 
of 21 feet), but there were 17 additional limbs with 
a measurement greater than 30 mm Hg and no 
palpable pedal pulse. After arterial reconstruction r
angioplasty, a transmetatarsal WcPO 2 level of 30 mm 
Hg or greater was highly accurate (96%, p = 
0.0003) in predicting a successful outcome. Ulti- 
mately, an initial or postintervention transmetatarsal 
TcPO 2 level of 30 mm Hg or greater was more 
accurate (90%, p = 0.001) than a palpable pulse 
(65%, p = 0.009) in predicting ultimate wound 
healing or resolution of rest pain. An ABI greater 
than 0.60 was also associated with a successful 
outcome (89%, p = 0.06), but because of noncom- 
pressible vessels, the ABI was only able to be 
calculated in 41/62 (66%) limbs (Table II). 
The total cost for TcPO 2 mapping of a lower 
extremity is $93.88. This figure includes direct and 
indirect facility costs ($56.70) for the 30-minute 
study with no variation in cost for a unilateral or 
bilateral study except for the increased time (an extra 
30 minutes) involved for the vascular technician, plus 
the current physician reimbursement based on the 
Medicare-RVU scale ($37.18). The total cost for a 
diagnostic lower extremity arteriogram, including 
nursing staff, supplies, usual room time of 2 hours, 
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Table II. Accuracy statistics for predicting resolution of diabetic foot salvage problems 
Predictive value 
Sensitivity Specificity Posit ive Negative Accuracy 
(%) (%) (%) (%) (%) 
Initial or postintervention transmetatarsal TcPO 2 _> 30 mm Hg 
(62/62 limbs): 
Palpable pedal pulse (62/62 limbs): 
ABI _> 0.60 (41/62 limbs): 
98 44 91 80 90 
60 89 97 28 65 
94 40 92 50 88 
Table I I I .  Algorithm for elective 
management of the patient with diabetes 
and limb-threatening foot ischemia 
If TM TcPO 2 _> 30 mm Hg (with or without a palpable 
pedal pulse 
Outpatient wound care, wound debridement, or mi- 
nor foot amputation 
If TM TcPO 2 < 30 mm Hg or conservative tr atment is 
unsuccessful after 4 to 6 weeks 
Arteriography, with revascularization as eeded 
IfTM TcPO 2 < 30 mm Hg and there is pedal edema or 
cellulitis 
Repeat test after esolution, before proceeding with ar- 
teriography 
For calcaneal gangrene/nonhealing ulcer 
Use higher TM TcPO2 threshold of 40 mm Hg or se- 
lective TcPO 2 mapping of the forefoot and hindfoot 
Arteriography after 2 to 4 weeks of unsuccessful con- 
servative treatment. 
TM, Transmetatarsal. 
and the procedure code, is $1052.73 ($485.45 for 
staff, supplies, and angiography suite, plus $107.93 
for outpatient charges, plus $459.35 for the allow- 
able professional component based on the Medicare- 
Relative Value Unit scale). 
DISCUSSION 
This study is unique in that TcPO 2 mapping was 
used prospectively to determine treatment for pa- 
tients with diabetes and limb-threatening ischemia. 
ABIs and pedal pulses were carefully recorded, but 
clinical decisions were based on an absolute trans- 
metatarsal TcPO 2 level of  30 mm Hg with the patient 
in the supine position and breathing room air. 9 A 
transmetatarsal TcPO 2 level greater than 30 mm Hg 
at the onset of conservative treatment or after arte- 
rial reconstruction/angioplasty was highly accurate 
(90%, p = 0.001) in predicting ultimate resolution 
of  pedal gangrene, nonhealing ulceration, or ischemic 
rest pain. 
As expected, in this group of patients with 
diabetes, an ABI could not be calculated in all limbs. 
Even with compressible vessels, ABIs were not 
reliable in predicting either abnormal arteriograms or
TcPO 2 levels (> 30 mm Hg) adequate to support 
major wound healing. However, the absence of a 
pedal pulse was highly predictive of an abnormal 
arteriography result, and a palpable pedal pulse was 
100% (21 of 21 limbs) correct in identifying feet 
with a transmetatarsal TcPO 2 greater than 30 mm 
Hg, 20 of which were successfully treated. Never- 
theless, 11 of 15 limbs without a palpable pulse but 
with a transmetatarsal TcPO 2 greater than 30 mm 
Hg also healed with conservative care only. Thus 
neither ABIs nor pedal pulses were sufficiently 
discriminating to be used to make a clinical decision 
with regard to ultimate wound healing or resolution 
of rest pain. 
I f  absence of pedal pulses had been the indication 
for arteriography, 45 limbs would have been sub- 
jected to this examination. In fact, only 31 limbs 
needed arteriography (27/28 limbs with an initial 
transmetatarsal TcPO 2 level ess than 30 mm Hg, and 
4/5 treatment failures with an initial transmetatarsal 
TcPO 2 level of 30 mm Hg or greater). The nones- 
sential 14 arteriograms would have cost $14,738.22. 
In contrast, the 14 TcPO 2 studies cost $1314.32. 
Certainly patients with diabetes and without 
pedal pulses do have arteriosclerotic lesions, some of  
which can be reconstructed. This study demonstrates 
that such surgical revascularization is not obligatory. 
In fact, well-performed TcPO 2 measurements can 
predict distal ischemic wound healing in 90% of 
cases. Furthermore, conservative management is not 
only cost-effective when compared with surgical or 
angioplasty revascularization, but time to lesion 
healing is not statistically significantly different be- 
tween the two groups (6.84 weeks vs 9.52 weeks, 
p = 0.169). 
A critical analysis of treatment failures and 
incorrect reatment selection demonstrates the falli- 
bility of TcPO 2 measurements in certain clinical 
situations and the complex nature of diabetic foot 
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problems. In the conservative treatment group, four 
of five treatment selection failures had a transmeta- 
tarsal TcPO 2 value less than 34 mm Hg and had 
calcaneal gangrene or nonhealing ulceration. The 
foot of  the fifth patient failed to improve with not 
only conservative care, but also with arterial recon- 
struction, and the patient underwent a BK amputa- 
tion despite an initial transmetatarsal TcPO 2 level of  
42 mm Hg. In the group of patients with an initial 
transmetatarsal TcPO 2 less than 30 mm Hg, one 
patient's transmetatarsal TcPO 2 level improved from 
1 to 19 after superficial femoral artery angioplasty, 
but the ulcerated foot lesion did not heal. She then 
had femorotibial bypass and a ftec-flap to cover the 
dorsum of her foot. The transmetatarsal TcPO 2 level 
improved to 30 mm Hg. This combined procedure 
was ultimately successful. One patient had pedal 
vessel exploration, but no suitable distal target vessel 
was found. He then failed a minor foot amputation. 
Two patients had a major amputation for ascending 
pedal sepsis despite a patent bypass graft. One other 
patient with pedal edema, cellulitis, and a transmeta- 
tarsal TcPO 2 measurement of 25 mm Hg had an 
unnecessary arteriogram, because the foot problem 
resolved with conservative care. Follow-up TcPO 2 
mapping demonstrated the transmetatarsal v lue to 
be greater than 30 mm Hg after resolution of pedal 
cellulitis and edema. 
An absolute transmetatarsal TcPO 2 level of  30 
mm Hg or greater appears to be an accurate cutoff 
point for the selection of conservative or operative 
treatment for almost all diabetic foot problems. The 
conservative management scheme, however, requires 
diligent patient follow-up. There must be a commit- 
mcnt by the surgeon to perform office dcbridements 
and staged procedures (i.e., minor foot amputations 
or split-thickness kin grafts). Proper outpatient 
wound care is essential. A higher transmetatarsal 
TcPO 2 threshold (40 mm Hg) may be required to 
manage successfully calcaneal gangrene or some very 
severe nonhealing ulcerations. 
An arteriographic abnormality that requires an- 
gioplasty or arterial reconstruction can be expected in 
most instances when the transmetatarsal TcPO 2 level 
is less than 30 mm Hg. However, cellulitis and 
significant foot edema may confound the accuracy of 
TcPO 2 mapping. In this circumstance, if the trans- 
metatarsal TcPO 2 level is found to be less than 30 mm 
Hg, the test should be repeated after hospitalization, 
bed rest, leg elevation, intravenous antibiotics, and 
resolution of  the edema. 
TcPO 2 mapping is accurate, noninvasive, and 
relatively inexpensive. The study can be used pro- 
spectively to select appropriate treatment (Table II I) 
for patients with diabetes and limb-threatening 
ischemia nd may obviate the need for arteriography 
to determine severity of foot ischemia, even in 
patients with diabetes without pedal pulses and low 
ABIs. 
We are grateful for editorial comments made by John 
J. Bergan, MD. 
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DISCUSSION 
Dr. James M. Malone (Phoenix, Ariz.). This prospec- 
tive randomized study evaluated 66 feet at risk in 55 
patients with diabetes. All patients were admitted with 
ischemic rest pain or tissue necrosis. Sixty percent of the 
patients had insulin-dependent diabetes, and 22% were 
undergoing long-term hcmodialysis. Patients were ran- 
domized into two study groups, conservative wound 
management with/without minor foot amputation or 
angiography with vascular econstruction and/or angio- 
plasty, on the basis of transcutancous oxygen measure- 
ments in the affected foot. A transcutaneous measurement 
of greater than 30 mm Hg led to conservative treatment, 
whereas a measurement of less than 30 mm Hg led to 
invasive diagnostic therapy. The study cndpoints were 
resolution of the presenting foot problem or death. The 
study duration was 1 year. 
This study concluded that 86% of patients with a 
transcutaneous oxygen measurement greater than 30 mm 
Hg healed with conservative therapy, whereas 83% of 
patients with a transcutaneous oxygen measurement less 
than 30 mm Hg healed after angioplasty or vascular 
reconstruction. In addition, the authors concluded that 
transcutaneous oxygen measurements were more accu- 
rate than pedal pulses or ABIs. The latter conclusion is to 
be expected given the noncompressible nature of the tibial 
arteries in patients with diabetic peripheral vascular 
disease. 
There were five patient/limb failures in the conservative 
therapy group. Four of the five failures were in patients 
with transcutancous oxygen measurements greater than 30 
mm Hg but less than 34 mm Hg. In addition, these failures 
were all associated with calcaneal gangrene. There were 
four limb failures in the invasivc therapy group and all 
failures occurred for the usual reasons. 
Why not raise your conservative threshold measure- 
ment to 35 mm Hg? That level would have given you a 
success rate of 35 of 36 patients. On the other hand, four 
of five failures occurred in patients with calcaneal gangrene. 
It is my guess that those patients form a special subgroup 
of diabetic foot problems. Should those patients be a special 
subgroup rather than included with other more typical 
diabetic foot problems? 
What did the artcriograms look like in the patients with 
calcaneal gangrene both before and after reconstruction? 
Most of us have had patients with successful distal tibial 
bypass procedures, but a "black hole" of nonperfusion over 
the area of calcaneal gangrene. Again, should these patients 
be stratified into a subgroup? 
This is a short-term study. What long-term follow-up 
is available? Do you plan to continue to monitor these 
patients? In addition, because the expected contralateral 
limb loss rate in this group of patients is 7% to 12% per 
year, what happened to the opposite limb/nonaffected 
extremity/foot? 
I encourage you to repeat his study as a multicenter, 
prospective randomized trial with stratification to help 
analyze insulin use, subgroup classification of diabetic foot 
problems, the role of patient education, foot and 
shoe/orthotic care, and the quality of patient follow-up. 
Dr. Jeffrey L. Ballard. Patients with calcaneal gan- 
grene form a special subgroup. The TcPO 2 threshold may 
need to be 35 or 40 mm Hg. As a result of this study, we 
pursue arteriography early if the TcPO 2 levels are marginal. 
These patients need aggressive treatment. It is not uncom- 
mon for the patient o need either a free vascularized tissue 
transfer or a local myocutaneous tissue rotation after 
revascularization. Even though arteriograms do occasion- 
ally show a "black hole," free flaps based on a distal bypass 
graft can be used to cover severely ischemic open wounds. 
Regarding the contralateral limb, two or three patients 
have had problems, and they are treated according to this 
algorithm. So far we have not seen limb loss in the 
contralateral limb, but our follow-up is short. 
With regard to long-term follow-up, we have a stable 
patient population. Long-term data on the management of 
these diabetic foot problems will be available in the next few 
years. 
Dr. Robert B. Rutherford (Denver, Colo.). I believe 
it's very difficult o apply a single absolute cutoffpoint, such 
as 30 mm Hg. I realize there's ome basis for this in the 
literature, as Dr. Malone has pointed out, but we found 
that, below 20 mm Hg, nothing is going to heal, and, 
above 40 mm Hg, almost everything will heal; but there's 
an in-between zone where it is not possible to predict 
healing with accuracy, and that's where a lot of these cases 
fall. 
So we've taken a diffkrent approach on the basis of the 
cost-effectiveness of starting with the cheapest test first. 
Darrell Jones worked out an algorithm for us to use. 
Basically, if we can get a pulsatile plethysmographic tracing 
near the level of the lesion, that tells us that healing will 
occur. 
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If the plethysmographic tracing is "flat line," then you 
take a toe pressure. The toe pressure has a similar range to 
the tissue oxygen level. Healing will not occur below 20 
mm Hg, but it will above 40 mm Hg. So that eliminates 
more at each end. Usually with those two inexpensive t sts 
that are readily performed in your vascular laboratory, ou 
are able to make the decision in more than 80% of the cases. 
If the results of these two simple tests don't decide it, we 
then go to tissue oxygen determinations, which take close 
to an hour to perform, with membrane warming and 
equilibration. 
For the calcaneal ulcers and unusual esions like that, 
which I agree are a special subgroup, that are hard to 
predict, we use thallium perfusion scanning. If you have a 
hyperemic zone around the lesion, with a more than 2:1 
ratio of hyperemia to background, then those can be 
expected to heal with conservative measures. 
So what I am suggesting is, rather than respond rigidly 
to values on either side of the single-tissue oxygen end 
point, you could use cheaper and more readily available 
tests in most of the cases and get the same or better esults 
and probably end up without the 14% failure rate you 
report. 
Dr. BaUard. We don't use the other noninvasive 
methods that you described. We specifically did not want 
to repeat a study of multiple different diagnostic modali- 
ties. Our goal was to choose one study (TcPO2), use it 
prospectively, and validate its ability to screen patients with 
diabetes for foot ischemia. 
Dr. Kaj H. Johansen (Seattle, Wash.). Dr. Rutherford 
makes the point that a patient with diabetes needs to have 
a toe to perform digital plethysmography, and I agree. We 
have unpublished ata that show a very high correlation 
between digital pressures and TcPO2s. There may be a real 
virtue in a study (digital plethysmography) that can be 
performed in 1 or 2 minutes rather than 30 minutes 
(TcPO2). 
That notwithstanding, this is a prospective randomized 
trial of an important modality in a patient population that 
we're going to be seeing more and more of. 
Dr. Calvin B. Ernst (Detroit, Mich.). We learned 
from Dr. Malone's discussion that 22% of the patients were 
undergoing dialysis. This is a subgroup of patients in whom 
we have had disappointing results after limb salvage 
procedures. They have dismal results after evascularization 
and frequently require amputations. Please expand on this 
subgroup. 
Dr. Ballard. We have looked at patients with diabetes 
undergoing popliteal-tibial bypass and patients with dia- 
betes and these foot problems and have not seen a decidcdly 
dismal result in those patients who were undergoing 
hemodialysis. We do not change our treatment algorithm 
for patients undergoing dialysis. 
Dr. Wil l iam J. Quifiones-Baldrich (Los Angeles, 
Calif.). Excluding patients who have calcaneal problems 
or gangrene where you can have a palpable dorsalis pedal 
pulse and still have a heel that is very ischemic, the group 
of patients who had palpable pulses were the ones that 
you were able to discriminate with TcPO 2 measurement. 
Those who did not have palpable pulses required an 
arteriogram and eventual revascularization. It seems to me 
the message here is that if the patient has a palpable pulse 
and no problem in the heel, that you probably can treat 
that patient conservatively and even skip the TcPO 2 
reserving the test for those patients who don't have a 
palpable pulse, helping to stratify those into conservative 
or more aggressive measures. Could you comment on 
that? 
Dr. Ballard. You are probably correct. A patient with 
diabetes with a palpable foot pulse will very likely have their 
foot problem heal with conservative treatment. In this 
prospective study every patient had TcPO 2 mapping. There 
will be an occasional patient in whom conservative 
treatment will fail with an adequate TcPO 2 level and a 
palpable foot pulse. 
Dr. J. Dennis Baker (Los Angeles, Calif.). I am 
concerned about your cost estimates. It appears that you are 
presuming that conservative management is based on 
outpatient therapy. 
At the Veterans Affairs Hospital, conservative therapy 
often ends up as hospitalization. So if you have a moderate 
to long hospitalization before you accept he fact that your 
conservative management has failed, you tack that onto the 
cost of the vascular econstruction and angiography. Was 
this factor considered in the cost estimates? 
Dr. Ballard. Conservative treatment was generally in 
an outpatient setting. We have very aggressive home health 
care nursing, which has been the key. Outpatient care has 
to be diligently monitored by the surgeon to be successful. 
Dr. Wesley S. Moore (Los Angeles, Calif.). This 
question is directed toward the failures in which you had 
calcaneal ulceration. If you've got a situation in which 
there's disconnection between the anterior and posterior 
circulation of the foot and if the ulceration is in the 
distribution of the posterior tibial artery, might you not 
have been able to improve your accuracy ifyou had sampled 
in a different location, either on the planar area or perhaps 
on the calcaneal skin? 
Dr. Ballard. Definitely. There are a number of patients 
who had segmental TcPO 2 mapping of the foot. Forefoot 
and hindfoot measurements are instructive because one 
area may look good, whereas other areas look thoroughly 
dismal. For this study, we did not stratify treatment on the 
basis of segmented foot TcPO 2 levels. 
Dr. Robert  L. Kistner (Honolulu, Hawaii). In our 
use of the TcPO 2 we've found that the placement of the 
probe is critical and have had some confusion of how close 
to the ulcer to place the probe, and how to handle the 
edematous foot. 
Could you give us some remarks about where that 
should be placed? Specifically, should it be placed at the 
point where you would expect he optimal flow at the mid 
foot or beyond, or should it be placed nearer the diseased 
location? 
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Dr. Ballard. Our vascular technicians are very knowl- 
edgeable with regard to TcPO 2 probe placement. We try to 
choose the most fleshy part of the forefoot, usually between 
the great and second toe. At times this can be difficult, 
especially in patients who have toe amputations orcellulitis 
present on the forefoot. We do not place the probe over 
either a tendon or a bony prominence because the readings 
may not be reliable. 
Dr. Stephen C. Nicholls (Seattle, Wash.). I appreciate 
this kind of data because we have transcutaneous oxygen 
measurements in the laboratory, and I always believe that 
there's acertain amount of gestalt to it. Anything more than 
20 raises your level of optimism. So we don't necessarily use 
a cutoff of 30 mm Hg, although, at less than 20 mm Hg 
it's usually impossible to get any healing. 
I think there's a very distinct group of these neuro- 
pathic ulcers that are not only calcaneal but can also be 
tarsal ulcers and are usually due to changes in propriocep- 
tion on weight bearing with or without a major ischemic 
component. We've seen patients with palpable foot pulses 
with major neuropathic ulcers whose transcutaneous oxy- 
gen is very high, and it becomes more a case of malting sure 
that infection is not present and of orthotic management. 
One thing we have done, and it's been done purely on 
an empiric basis, is to take two measurements, one distal at 
the base of the toes and one fairly proximal, in other words, 
either side of the cutting line for a transmetatarsal 
amputation. I wonder if you had any experience with this 
because for us it's been reasonably helpful to decide 
whether a transmetatarsal amputation is going to heal. 
Dr. Ballard. As a routine, we did not segmentally map 
the foot. In our current algorithm, we are measuring both 
forefoot and hindfoot TcPO 2 levels. 
Dr. Jerry Goldstone (San Francisco, Calif.). Did you 
say that only 48% of the patients with a low TcPO 2 had an 
abnormal angiography result? 
Dr. BaUard. Ninety-six percent of patients with a low 
TcPO 2 level had an abnormal arteriography result. The 
overall accuracy of a palpable pedal pulse in predicting 
ultimate wound healing was 65%, whereas the accuracy of 
a transmetatarsal TcPO 2 level at 30 mm Hg or greater was 
90%. 
